EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
metrics 2024
Navigating the Landscape of Molecular Diagnostics
Introduction
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, published by Taylor & Francis AS, serves as a pivotal platform for facilitating advanced research and discourse in the fields of Genetics, Molecular Biology, Molecular Medicine, and Pathology. With an impressive Impact Factor and a distinguished status as Q2 in multiple categories, along with a prestigious Q1 ranking in Pathology and Forensic Medicine (2023), this journal continues to attract contributions from leading experts and budding researchers alike. The journal aims to address critical developments in molecular diagnostics, providing insightful reviews that propel the understanding and application of diagnostic techniques in various medical contexts. Accessible to a diverse audience in the academic community, the journal emphasizes the importance of molecular diagnostics in both clinical and laboratory settings, promoting innovative methodologies and comprehensive evaluations of emerging technologies. With ongoing convergence of scientific discovery advancing rapidly from 2001 through 2024, EXPERT REVIEW OF MOLECULAR DIAGNOSTICS remains essential for those committed to furthering the fields of molecular diagnostics and healthcare advancements globally.
Metrics 2024
Metrics History
Rank 2024
Scopus
IF (Web Of Science)
JCI (Web Of Science)
Quartile History
Similar Journals
Annual Review of Pathology-Mechanisms of Disease
Advancing Insights in Pathology and Disease MechanismsAnnual Review of Pathology: Mechanisms of Disease is a premier scholarly journal published by ANNUAL REVIEWS that systematically reviews significant advancements in the field of pathology and the mechanisms underpinning various diseases. With an ISSN of 1553-4006 and an E-ISSN of 1553-4014, the journal has established its importance within the academic community, evidenced by its prestigious Q1 rankings in several categories including medicine, pathology, forensic medicine, and plant science for 2023. Notably, it ranks #1 out of 208 in the pathology and forensic medicine category, placing it in the 99th percentile according to Scopus metrics. Although not an open-access journal, it offers crucial insights to researchers, professionals, and students alike by providing a comprehensive understanding of pathophysiological concepts and emerging trends. The journal continues to be an essential resource for those dedicated to advancing research and practical applications in disease mechanisms.
JOURNAL OF CLINICAL LABORATORY ANALYSIS
Transforming research into real-world laboratory solutions.JOURNAL OF CLINICAL LABORATORY ANALYSIS is a premier, peer-reviewed journal published by WILEY, focusing on the expansive field of laboratory medicine. With its ISSN 0887-8013 and E-ISSN 1098-2825, this open access journal has been serving the scientific community since 1987. As of 2023, it holds a notable impact in various domains, achieving category quartiles in Biochemistry, Clinical Biochemistry, Hematology, and more, showcasing its significance across multiple disciplines such as Medical Laboratory Technology and Public Health. Ranked impressively, it is placed 7th in Medical Laboratory Technology, reflecting its crucial role in advancing clinical practice and research. The journal aims to disseminate innovative research findings, methodologies, and reviews that can catalyze advancements in laboratory practices and improve patient outcomes. Accessible to a global audience since its transition to open access in 2019, the journal is not just limited to professionals but is also a valuable resource for students and researchers seeking to stay updated in this dynamic field. For more information, visit the journal's website.
MOLECULAR MEDICINE
Advancing the Frontiers of Genetics and Molecular BiologyMOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.
Cancer Genetics
Bridging Genetics and Cancer for a Healthier TomorrowCancer Genetics is an esteemed peer-reviewed journal dedicated to advancing the field of cancer research through the lens of genetics. Published by Elsevier Science Inc and available in both print (ISSN: 2210-7762) and online (E-ISSN: 2210-7770), this journal aims to provide a platform for the dissemination of high-quality studies that unravel the genetic underpinnings of cancer. Since its inception in 2011, Cancer Genetics has become a significant resource for researchers, professionals, and students with a shared interest in understanding the intricate relationship between genetics and oncogenesis. With an impact factor that reflects its influence, the journal has maintained a Q3 ranking in Cancer Research, Genetics, and Molecular Biology as of 2023, indicating its growing importance in these fields. Additionally, the journal offers open access options to ensure that crucial findings are easily accessible to the global research community. By bridging the gap between genetics and cancer studies, Cancer Genetics plays a pivotal role in fostering innovation and collaboration among scientists and clinicians striving to improve cancer diagnosis and treatment.
Biomarker Research
Unlocking the potential of biomarkers in clinical innovation.Biomarker Research is a leading open access journal published by BMC, dedicated to advancing the field of biomarker discovery and clinical application. Since its inception in 2013, this journal has become a crucial resource for researchers and professionals in biochemistry, clinical biochemistry, and molecular medicine, achieving a prestigious Q1 ranking in each category in 2023. With an E-ISSN of 2050-7771, it maintains a strong reputation for disseminating high-quality research and innovative findings that contribute to the understanding of disease mechanisms and the development of novel diagnostics and therapeutics. The journal is accessible to a global audience, ensuring that vital research is freely available to promote collaboration and accelerate scientific progress. Operating out of the United Kingdom, Biomarker Research plays a significant role in addressing some of the most pressing challenges in medical research, making it an essential resource for academics, clinicians, and industry professionals alike.
ANNALES DE BIOLOGIE CLINIQUE
Advancing the Frontiers of Clinical BiologyANNALES DE BIOLOGIE CLINIQUE is a prominent French journal dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Immunology, and Microbiology. Published by JOHN LIBBEY EUROTEXT LTD, this journal has been a pivotal resource since its inception in 1945, offering a rich archive of original research, reviews, and clinical studies that aim to bridge the gap between laboratory findings and clinical applications. Despite its ranking in the Q4 quartile within several scientific categories according to the 2023 Scopus rankings—positioning it at #395/636 in General Medicine and #198/221 in General Biochemistry—ANNALES DE BIOLOGIE CLINIQUE serves as a vital platform for emerging researchers and seasoned professionals alike, fostering collaboration and innovation in these vital areas of health science. As an essential tool for researchers and scholars, the journal does not currently provide open access; however, it continuously strives to enhance its impact and visibility in the scientific community through rigorous peer-reviewed content and educational contributions.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
Connecting researchers with vital scientific knowledge.The Scandinavian Journal of Clinical & Laboratory Investigation is a premier publication in the fields of clinical biochemistry and laboratory medicine, published by Taylor & Francis Ltd in the United Kingdom. With an ISSN of 0036-5513 and E-ISSN 1502-7686, this journal has been a vital source of scholarly articles since its inception in 1949, and is set to celebrate over seventy-five years of contributing to scientific knowledge in 2024. Ranked in the Q2 category for both Clinical Biochemistry and Medicine (Miscellaneous), it holds a robust position within the Scopus rankings, with a commendable rank of 77/117 in its discipline. The journal is dedicated to advancing research by offering a platform for high-quality studies that explore the development and application of clinical and laboratory investigations, making it essential reading for researchers, practitioners, and students interested in the latest advances and methodologies in the field. Although it does not currently offer Open Access, a wealth of valuable research insights awaits readers within its pages, highlighting its crucial role in fostering communication and innovation in clinical sciences.
HLA
Exploring the Frontiers of Histocompatibility and Antigen ResearchHLA, published by WILEY, is a distinguished academic journal that serves as a vital resource in the fields of Immunology, Genetics, and Allergy. With an ISSN of 2059-2302 and an E-ISSN of 2059-2310, HLA aims to provide cutting-edge research and developments that expand our understanding of human immunology, particularly concerning histocompatibility and antigen systems. Although it currently holds a Q4 quartile ranking in several categories—including Genetics and Immunology—it offers a platform for innovative studies that can catalyze new insights within the scientific community. The journal operates on an Open Access model, ensuring broader accessibility and engagement with emerging discoveries. Researchers, healthcare professionals, and students alike are encouraged to contribute to and utilize this journal to foster advancements in this rapidly evolving field. For submissions and more information, authors can navigate directly to its online portal, embracing the ongoing discourse in immunological research.
Byulleten Sibirskoy Meditsiny
Fostering Knowledge Exchange in the Heart of SiberiaByulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.
JOURNAL OF CLINICAL PATHOLOGY
Empowering Pathologists with Cutting-edge ResearchJOURNAL OF CLINICAL PATHOLOGY, published by BMJ PUBLISHING GROUP, stands at the forefront of advancements in the field of clinical pathology, offering a platform for groundbreaking research and insights from 1948 to the present. With an impressive impact factor and categorized as Q1 in both Medicine (miscellaneous) and Pathology and Forensic Medicine for 2023, the journal holds a distinguished position in the academic community, ranking 22nd out of 208 journals in its category on Scopus and representing the 89th percentile. While the journal does not currently offer open access, it remains a vital resource for researchers, healthcare professionals, and students seeking to stay current with innovative methodologies, clinical techniques, and diagnostic advancements. Located in London, United Kingdom, the journal aims to bridge the gap between laboratory findings and clinical practice, emphasizing the importance of evidence-based pathology in improving patient care and treatment outcomes. Engage with the JOURNAL OF CLINICAL PATHOLOGY to enhance your understanding and contribute to the evolving landscape of clinical pathology research.